These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 7191261)

  • 1. [The diuretic activity of bumetanide in a controlled comparison with furosemide in patients with various degrees of impaired renal function (author's transl)].
    Kampf D; Baethke R
    Arzneimittelforschung; 1980; 30(6):1015-8. PubMed ID: 7191261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic and natriuretic effects of bumetanide and furosemide in the cat.
    Friedman PA; Roch-Ramel F
    J Pharmacol Exp Ther; 1977 Oct; 203(1):82-91. PubMed ID: 909060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of loop diuretics in patients with chronic renal insufficiency.
    Voelker JR; Cartwright-Brown D; Anderson S; Leinfelder J; Sica DA; Kokko JP; Brater DC
    Kidney Int; 1987 Oct; 32(4):572-8. PubMed ID: 3430953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute effects of bumetanide in healthy subjects. A comparative study with furosemide (author's transl)].
    Ortź González A; Méndez Martin A
    Med Clin (Barc); 1979 Mar; 72(6):259-64. PubMed ID: 379471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bumetanide, a new diuretic active during chronic renal failure (author's transl)].
    Fries D; Beroniade V; Coy JL; Delavelle F
    Pathol Biol (Paris); 1976 Jun; 24(6):435-9. PubMed ID: 785349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Result of the administration of high doses of bumetanide to patients with chronic renal failure who are on a program of hemodialysis (author's transl)].
    del Río Vázquez A; Carrera Carbó F; Arcocha Gilo V; Torrente Sierra J
    Med Clin (Barc); 1979 Jan; 72(2):71-3. PubMed ID: 431166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diuretic effects of subcutaneous furosemide in human volunteers: a randomized pilot study.
    Verma AK; da Silva JH; Kuhl DR
    Ann Pharmacother; 2004 Apr; 38(4):544-9. PubMed ID: 14982985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative diuretic and tissue distribution study of bumetanide and furosemide in the dog.
    Cohen MR; Hinsch E; Vergona R; Ryan J; Kolis SJ; Schwartz MA
    J Pharmacol Exp Ther; 1976 Jun; 197(3):697-702. PubMed ID: 932999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of bumetanide in nephrotic syndrome: a double-blind crossover study with furosemide.
    Lau K; DeFronzo R; Morrison G; Rascoff J; Goldberg M; Agus ZS
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):489-97. PubMed ID: 789411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative randomized double-blind clinical trial of bumetanide and furosemide in congestive cardiac failure and other edema states.
    Sagar S; Sharma BK; Sharma PL; Wahi PL
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):473-8. PubMed ID: 6389378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some aspects of the renal action and clinical pharmacology of oral bumetanide in man.
    Bourke E
    Postgrad Med J; 1975; 51 Suppl 6():23-26. PubMed ID: 1105529
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diuretic evaluation of bumetanide (author's transl)].
    Barrientos Guzmán A; Ortuño de Solo MT
    Med Clin (Barc); 1979 Nov; 73(8):338-41. PubMed ID: 522529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bumetanide and frusemide: a comparison of dose-response curves in healthy men.
    Ramsay LE; McInnes GT; Hettiarachchi J; Shelton J; Scott P
    Br J Clin Pharmacol; 1978 Mar; 5(3):243-7. PubMed ID: 656269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diuretic action of bumetanide in advanced chronic renal insufficiency.
    Berg KJ; Tromsdal A; Wideroe TE
    Eur J Clin Pharmacol; 1976 Feb; 9(4):265-75. PubMed ID: 786692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease.
    Sanjay S; Annigeri RA; Seshadri R; Rao BS; Prakash KC; Mani MK
    Nephrology (Carlton); 2008 Jun; 13(3):247-50. PubMed ID: 18315706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observations of the early diuretic response after intravenous administration of bumetanide and furosemide in dogs.
    Olsen UB
    Acta Physiol Scand; 1975 Feb; 93(2):195-201. PubMed ID: 1146571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Step-dose of muzolimine at different stages of chronic renal failure: comparison with furosemide.
    Morachiello P; Coli U; Landini S; Fracasso A; Righetto F; Scanferla F; Bazzato G
    Z Kardiol; 1985; 74 Suppl 2():115-20. PubMed ID: 4002784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance.
    Givertz MM; Massie BM; Fields TK; Pearson LL; Dittrich HC;
    J Am Coll Cardiol; 2007 Oct; 50(16):1551-60. PubMed ID: 17936154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
    Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
    Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral bumetanide in chronic renal failure.
    Allison ME; Lindsay MK; Kennedy AC
    Postgrad Med J; 1975; 51 Suppl 6():47-50. PubMed ID: 1105533
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.